Ligand validation:1WDM

ACO: ACETYL COENZYME *A

ACO is a Ligand Of Interest in 1WDM designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
1WDM_ACO_D_4001	6%	58%	0.391	0.836	0.77	0.85	-	3	0	0	100%	1
1WDM_ACO_C_3001	3%	54%	0.441	0.765	0.84	0.92	1	2	0	0	100%	1
1WDM_ACO_A_1002	0%	56%	0.576	0.571	0.8	0.9	1	3	2	0	100%	1
1WDK_ACO_D_4001	12%	58%	0.259	0.785	0.75	0.87	1	2	5	0	100%	1
2D3T_ACO_C_1003	4%	56%	0.36	0.749	0.78	0.9	1	3	0	0	100%	1
1WDL_ACO_D_4001	4%	58%	0.387	0.768	0.91	0.72	1	2	4	0	100%	1
4HKF_ACO_A_201	100%	25%	0.039	0.987	1.52	1.52	7	5	1	0	100%	1
4IF5_ACO_A_201	99%	20%	0.046	0.98	2.16	1.25	12	7	1	0	100%	1
3R96_ACO_B_400	99%	54%	0.056	0.985	0.72	1.04	-	3	0	0	100%	1
4B5O_ACO_A_1197	99%	50%	0.065	0.993	1.05	0.87	4	-	0	0	100%	1
5LS7_ACO_B_203	98%	35%	0.059	0.983	1.07	1.48	3	10	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.